Your SlideShare is downloading. ×
Continuous Glucose Monitoring Market Reports
Continuous Glucose Monitoring Market Reports
Continuous Glucose Monitoring Market Reports
Continuous Glucose Monitoring Market Reports
Continuous Glucose Monitoring Market Reports
Continuous Glucose Monitoring Market Reports
Continuous Glucose Monitoring Market Reports
Continuous Glucose Monitoring Market Reports
Continuous Glucose Monitoring Market Reports
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Continuous Glucose Monitoring Market Reports

45

Published on

With the help of continuous glucose monitoring, noteworthy progression has been possible to stabilize a high A1C level, which lower downs the risk of diabetic complications. Few other factors that …

With the help of continuous glucose monitoring, noteworthy progression has been possible to stabilize a high A1C level, which lower downs the risk of diabetic complications. Few other factors that contribute towards the market growth are technological modernization such as artificial pancreas, rising awareness among developed, developing and under developed economies, and rising pool of diabetic patients.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
45
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) - Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts, 2012 - 2020 Published: Dec 2013 Pages: 92 Contact Us: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 Mail us: sales@reportsandintelligence.com Detailed report at: http://www.reportsandintelligence.com/continuous-glucose- monitoring-cgm-market
  • 2. Adoption of CGM- continuous glucose monitoring is a result of innovative diabetic management devices. Loopholes that exist in the present glucose monitoring devices are efficiently addressed by the pioneering CGM. With the help of continuous glucose monitoring, noteworthy progression has been possible to stabilize a high A1C level, which lower downs the risk of diabetic complications. Few other factors that contribute towards the market growth are technological modernization such as artificial pancreas, rising awareness among developed, developing and under developed economies, and rising pool of diabetic patients. Conversely, factors such as stern authoritarian impositions, lack of reimbursement options, less accurate results and high cost of the CGMs are impeding the growth of market. The report analyzed the global continuous glucose monitors market to generate revenue of $568.5 million by 2020, enrolling a CAGR of 14.8% during 2013-2020. This is due to technological advancements, to be exact, the launch of artificial pancreas, expediency that the CGMs have over self-monitoring glucose devices, and earlier detection of the hypo & hyperglycemic events by CGM. In terms of application, the Global CGM market is divided into diagnostics, home settings, and hospitals. The home settings segment would be the maximum revenue generator by 2020. North America generates maximum revenue due to wider adoption of advanced technologies, effective and well penetrated reimbursement policies, and rising cases of diabetics. Asia Pacific would grow fastest due to rising pool of patients, per capita income and awareness among the people. Top market participants in the market are Medtronics, Animas Corporation, Dexcom, Omnipod and Miraculins, Inc, Ypsomed AG, inlcuding others. The main tactics adopted by the companies globally include collaborations, product launches and approvals. Collaborations in the regions focus on distribution and commercialization of the devices. KEY BENEFITS  The report ranks the factors that are responsible to accelerate the market growth driven by upper hand of CGM over Self monitoring glucose devices, approval for artificial pancreas and many more  Market is forecast for the period 2013 - 2020 with market revenues for 2 historic years of 2010 and 2012  Identification and analysis of key pockets of investment for CGM manufacturers  Identification of challenges that must be addressed and overcome in the CGM market to achieve fiscal success throughout the market  Analysis of regulatory framework that regulates introduction of new CGM and puts light on reimbursement scenario
  • 3.  The report identifies and profiles key market participants that would drive innovation in the CGM market KEY MARKET SEGMENTS GLOBAL MARKET, BY DEVICES  Transmitter and Receivers  Sensors  Insulin Pump GLOBAL MARKET, BY APPLICATION  Diagnostics/Clinics  Hospitals  Home Settings GLOBAL MARKET, BY AGE  Children and Teens  Youth  Middle, Elderly and Aged GLOBAL MARKET, BY GEOGRAPHY  North America  Europe  Asia Pacific  Row KEY AUDIENCES  Medical Devices Manufacturers  Research Institutions  Healthcare Institutions
  • 4. Table of Content CHAPTER 1 INTRODUCTION 1.1 ObjectivesandScope 1.2 ReportDescription 1.3 KeyBenefitsof the Report 1.4 ResearchMethodology CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 GLOBAL CONTINUOUS GLUCOSEMONITORS MARKET OVERVIEW 3.1 Healthcare ExpenditureonDiabetesWorldwide 3.2 Type-1DiabeticstoRemainKeyTargetfor CGM Market 3.2.1 Type-1Diabetes 3.2.1.1 Type-1DiabetesinYoungPeople 3.2.2 Type-2Diabetes 3.2.2.1 Type-2DiabetesinYoung People 3.2.3 Gestational Diabetes 3.2.4 OtherTypesof Diabetes 3.3 Market Intelligence 3.3.1 Top Factors ImpactingContinuousGlucose MonitorsMarket,2013-2020 3.3.1.1 Fda Approval of Artificial Pancreas 3.3.1.2 Convenience OfferedbyCGMOverSelf MonitoringGlucose Devices 3.3.1.3 Rise inIncidencesof DiabetesCasesGlobally 3.3.1.4 EarlierDetectionof the Hypoand HyperglycemicEventsbyCGM 3.3.1.5 Inadequate ReimbursementOptionsforCGMServe asBarriersfor itsAdoption 3.3.1.6 Accuracy and Cost Actsas a Hindrance inContinuingUse of CGM 3.3.1.7 Strict RegulatoryImpositions 3.3.1.8 Increase inAwarenessAmongDevelopingandUnderdevelopedEconomies 3.3.2 Top Three WinningStrategiesinthe ContinuousGlucose MonitorsMarket 3.3.2.1 Global Market PlayersPositioning 3.3.3 Top InvestmentPocketsinContinuousGlucose MonitorsMarket 3.3.3.1 ContinuousGlucose MonitorsMarket – by Device 3.3.3.2 ContinuousGlucose MonitorsMarket – by Applications 3.3.3.3 ContinuousGlucose MonitorsMarket – by Geography 3.4 Regulations 3.5 ReimbursementScenario 3.6 Market Dynamics 3.6.1 Drivers 3.6.1.1 Convenience OfferedbyCGMOverSelf MonitoringGlucose Devices 3.6.1.2 FDA Approval of Artificial PancreasEnablesClosingthe LoopandOvercomesthe Limitation of CurrentDiabetesCare ManagementSystem 3.6.1.3 EarlierDetectionof the Hypoand HyperglycemicEventsbyCGM
  • 5. 3.6.1.4 Rise in Incidencesof DiabetesCasesGlobally 3.6.1.5 Increase inAwarenessAmongthe PopulationinDevelopingandUnderdevelopedEconomies 3.6.2 Restraints 3.6.2.1 Strict RegulatoryImpositions 3.6.2.2 Inadequate ReimbursementOptionsforCGMServe asBarriersfor itsAdoption 3.6.2.3 Accuracy and Cost Actsas a Hindrance inContinuingUse of CGM 3.6.3 Market Opportunity 3.6.3.1 Growth inEmergingMarket 3.6.4 WinningStrategiesforMncsin EmergingMarkets 3.6.4.1 Tailoringthe ExistingProductstothe Local Market Needs 3.6.4.2 Adoptionof a Proactive HybridModel RatherThanDistributorManagement 3.6.4.3 Service RenderedMakesaDifference 3.6.4.4 PartnershipandAcquisitionKeytoEnhance Reachand Market Position 3.6.4.5 AdoptingAnEmerging-MarketAttitude CHAPTER 4 CONTINUOUS GLUCOSEMONITORING SYSTEMS MARKET - BY DEVICES 4.1 TransmitterandReceivers 4.2 Sensors 4.2.1 Market Trend 4.2.1.1 Non-InvasiveGlucose Sensors 4.2.1.2 SubcutaneousSensors(MinimallyInvasive Sensors) 4.2.1.3 Conventional Technology –Holter-TypeRetrospective Sensors 4.2.1.4 AdvancedTechnology –Real-Time Sensors 4.3 InsulinPump 4.3.1 Advantagesof InsulinPump 4.3.2 Disadvantagesof InsulinPump 4.3.3 Market Trend CHAPTER 5 CONTINUOUS GLUCOSEMONITORING SYSTEM MARKET - BY APPLICATION 5.1 Diagnostics/Clinics 5.2 Hospitals 5.3 Home Settings 5.4 Role of CGM in Private Practice 5.4.1 Team Members 5.4.2 Clinical Space 5.4.3 Scheduling 5.4.4 Keepingthe PatientsInformed CHAPTER 6 CONTINUOUS GLUCOSEMONITORING SYSTEM MARKET – BY AGE 6.1 ChildrenandTeens 6.2 Youth 6.3 Middle ElderlyandAged
  • 6. CHAPTER 7 CGM SYSTEMS MARKETBY GEOGRAPHY 7.1 NorthAmerica 7.2 Europe 7.2.1 Financial CostIncurred 7.3 AsiaPacific 7.4 Row CHAPTER 8 COMPANY PROFILES 8.1 MedtronicInc. 8.1.1 CompanyOverview 8.1.2 CompanySnapshot 8.1.3 BusinessPerformance 8.1.4 StrategicMovesand Developments 8.1.4.1 Principal Strategies:ProductLaunch 8.1.4.2 SecondaryStrategies:Approval 8.1.4.3 OtherStrategies:Collaboration 8.1.5 SWOT Analysis&StrategicConclusions 8.2 DexcomInc. 8.2.1 CompanyOverview 8.2.2 CompanySnapshot 8.2.3 BusinessPerformance 8.2.4 StrategicMovesand Developments 8.2.4.1 Principal Strategies:Agreement/Partnership 8.2.4.2 SecondaryStrategies:Acquisition 8.2.5 SWOT Analysis&StrategicConclusions 8.3 NovoNordisk 8.3.1 CompanyProfile 8.3.2 CompanySnapshot 8.3.3 StrategicMovesand Developments 8.3.4 SWOT Analysis&StrategicConclusions 8.4 SpringHealthSolutionLtd 8.4.1 CompanyProfile 8.4.2 CompanySnapshot 8.4.3 StrategicMovesand Developments 8.4.3.1 Principal Strategies 8.4.4 SWOT Analysis&StrategicConclusions 8.5 Roche 8.5.1 CompanyProfile 8.5.2 CompanySnapshot 8.5.3 StrategicMovesand Developments 8.5.4 SWOT Analysis&StrategicConclusions 8.6 AnimasCorporation 8.6.1 CompanyProfile 8.6.2 CompanySnapshot 8.6.3 StrategicMovesand Developments 8.6.3.1 Principal Strategies
  • 7. 8.6.4 SWOT Analysis&StrategicConclusions 8.7 YpsomedAG 8.7.1 CompanyProfile 8.7.2 CompanySnapshot 8.7.3 StrategicMovesand Developments 8.7.3.1 Principal Strategies:ProductExpansion 8.7.3.2 SecondaryStrategies:NewSubsidiary 8.7.3.3 OtherStrategies:AcquisitionandAgreements 8.7.4 SWOT Analysis&StrategicConclusions 8.8 InsuletCorporation 8.8.1 CompanyProfile 8.8.2 CompanySnapshot 8.8.3 StrategicMovesand Developments 8.8.3.1 Principal Strategies 8.8.4 SWOT Analysis&StrategicConclusions LIST OF TABLES: TABLE 1 FEATURES OF CURRENTLY AVAILABLESTAND-ALONECGMSYSTEMS (ASOF MARCH 2013) TABLE 2 FEATURES OF CURRENTLY AVAILABLEINTEGRATEDCGM SYSTEMS (ASOF MARCH 2013) TABLE 3 GLOBAL CONTINUOUSGLUCOSE MONITORINGSYSTEMS MARKET BY PRODUCT CATEGORY, 2011-2020, ($MILLION) TABLE 4 GLOBAL CGM TRANSMITTERS ANDRECEIVERSMARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION) TABLE 5 GLOBAL CGM SENSORSMARKET BY GEOGRAPHY,2011 - 2020, ($MILLION) TABLE 6 GLOBAL CGM INSULIN PUMP MARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION) TABLE 7 GLOBAL CGM MARKET BY APPLICATION SEGMENTS,2011 - 2020, ($MILLION) TABLE 8 GLOBAL CGM MARKET IN DIAGNOSTICCENTERS,BY GEOGRAPHY, 2011 - 2020, ($THOUSAND) TABLE 9 GLOBAL CGM MARKET IN HOSPITALS,BY GEOGRAPHY,2011 - 2020, ($THOUSAND) TABLE 10 GLOBAL CGM MARKET IN HOME SETTINGS,BY GEOGRAPHY, 2011 - 2020, ($MILLION) TABLE 11 GLOBAL CGM MARKET BY AGE, 2011 - 2020, ($MILLION) TABLE 12 TYPE-1 DIABETES(0-14 YEARS),2013 TABLE 13 FACTORSIMPACTINGGEOGRAPHICAL REGIONSIN 2013 AND 2020 TABLE 14 GLOBAL CONTINUOUSGLUCOSE MONITORINGSYSTEMS BY GEOGRAPHY, 2011 - 2020, ($MILLION) TABLE 15 THE PREVALENCEOF DIABETESIN THE ADULT POPULATION ACROSSTHE U.K. IN 2011 TABLE 16 PREVALENCEESTIMATES OF DIABETES (20-79 YEARS),2013, EUROPE TABLE 17 PREVALENCEESTIMATES OF DIABETES,2013 & 2035 TABLE 18 PREVALENCEESTIMATES OF DIABETES (20-79 YEARS),2013, AFRICA REGION TABLE 19 MEDTRONIC BUSINESS SNAPSHOT TABLE 20 DEXCOM INC.BUSINESSSNAPSHOT TABLE 21 NOVA NORDISKBUSINESSSNAPSHOT TABLE 22 SPRINGHEALTH SOLUTION LTD BUSINESSSNAPSHOT TABLE 23 ROCHE BUSINESSSNAPSHOT TABLE 24 ANIMASCORPORATION BUSINESSSNAPSHOT
  • 8. TABLE 25 YPSOMED AG BUSINESSSNAPSHOT TABLE 26 INSULET CORPORATION BUSINESSSNAPSHOT LIST OF FIGURES: FIG. 1 GLOBAL HEALTH EXPENDITURE DUE TO DIABETES, BY GEOGRAPHY ($BILLION) FIG. 2 GLOBAL HEALTH EXPENDITURE DUE TO DIABETES,20-79 YEARS ($BILLION) FIG. 3 TREATMENT OF DIABETES,2011 FIG. 4 SIMILARITIES IN CAUSE OF PRE-DIABETESANDTYPE-2 DIABETES FIG. 5 CGM ADOPTION BY DIFFERENTTYPES OFDIABETES PATIENTS FIG. 6 PREVALENCEOF TYPE-1 DIABETES, BY GEOGRAPHY, (THOUSAND) FIG. 7 GLOBAL PREVALENCEOFTYPE-2 DIABETES IN 2000 & ESTIMATED PREVALENCEIN 2030 FIG. 8 TOP FACTORSIMPACTINGCGM MARKET, 2013-2020 FIG. 9 TOP WINNINGSTRATEGY IN CGMMARKET, 2010 TO 2013 (SEPTEMBER) FIG. 10 TOP WINNINGSTRATEGY IN CGM MARKET BY YEAR FIG. 11 GLOBAL MARKET PLAYERS POSITIONING FIG. 12 TOP INVESTMENTPOCKETSIN CGM DEVICE MARKETS FIG. 13 TOP INVESTMENTPOCKETSIN CGM APPLICATION MARKETS FIG. 14 TOP INVESTMENTPOCKETSIN CGM GEOGRAPHY MARKETS FIG. 15 NUMBER OF INCIDENCESOFDIABETESGLOBALLY, BY GEOGRAPHY (2000, 2011 & 2030) FIG. 16 GDP PER CAPITA IN EMERGING ECONOMIES FIG. 17 EMERGING MARKET CAPITALIZATION STRATEGIES FIG. 18 GLOBAL CGM MARKET AMONG CHILDREN,2011-2020, ($MILLION) FIG. 19 GLOBAL CGM MARKET AMONG TEENS, 2011-2020, ($MILLION) FIG. 20 GLOBAL CGM MARKET AMONG YOUTH, 2011-2020, ($MILLION) FIG. 21 GLOBAL CGM MARKET AMONG MIDDLE ELDERLY, 2011-2020, ($MILLION) FIG. 22 GLOBAL CGM MARKET AMONG AGED, 2011-2020, ($MILLION) FIG. 23 NORTH AMERICA CGM MARKET, 2013-2020, ($MILLION) FIG. 24 CASESOF DIABETES BY AGES IN NAC(1000S) (2013 E) FIG. 25 EUROPE CGM MARKET, 2013-2020, ($MILLION) FIG. 26 CASESOF DIABETES BY AGES IN EUROPE (1000S) (2013 E) FIG. 27 ASIA PACIFICCGMMARKET, 2013-2020, ($MILLION) FIG. 28 TOP 10 COUNTRIESWITH DIABETESINCIDENCES2013 AND2035 FIG. 29 ROW CGM MARKET, 2013-2020, ($MILLION) FIG. 30 FINANCIALREVENUESBYBUSINESS UNITS (2013) FIG. 31 FINANCIALREVENUESBYGEOGRAPHY (2013) FIG. 32 FINANCIALREVENUES BYGEOGRAPHY (2012)
  • 9. Contact Us: Sona Padman 5320 SW MacadamAvenue, Suite 100, Portland, OR97239 United States Direct: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 (U.S. & Canada) Fax: +1 (855) 550-5975 Email: sales@reportsandintelligence.com Web: http://www.reportsandintelligence.com/

×